Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Hoffmann · SciRah

Researcher profile · Semantic Scholar

M. Hoffmann

Share profile

M. Hoffmann — researcher profile on SciRah

h-index: 17
Works: 47
Citations: 1,168

Most-cited papers

The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature
S. M. Wallerstedt, B. Wettermark, M. Hoffmann
2016Basic & Clinical Pharmacology & Toxicology250 citations Open access
Semantic Scholar
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B. Godman, B. Wettermark, M. Hoffmann, K. Andersson +2 more
2009Expert review of pharmacoeconomics & outcomes research169 citations
Semantic Scholar
Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
R. Malmström, B. Godman, E. Diògene, Christoph Baumgärtel +43 more
2013Frontiers in Pharmacology97 citations Open access
Semantic Scholar
Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
M. Hoffmann, M. Hammar, K. Kjellgren, L. Lindh-Åstrand +1 more
2005Maturitas83 citations
Semantic Scholar
Women's conception of the menopausal transition--a qualitative study.
L. Lindh-Åstrand, M. Hoffmann, M. Hammar, K. Kjellgren
2007Journal of Clinical Nursing69 citations Open access
Semantic Scholar
Pharmacokinetics of nicotine in kidney failure
L. Molander, Anna Hansson, E. Lunell, Lisbeth Alainentalo +2 more
2000Clinical pharmacology and therapy55 citations
Semantic Scholar
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden.
B. Pettersson, M. Hoffmann, P. Wändell, L. Levin
2012Health Policy40 citations
Semantic Scholar
The prevalence of symptoms possibly related to the climacteric in pre- and postmenopausal women in Linköping, Sweden.
Charlotte Jansson, S. Johansson, L. Lindh-Åstrand, M. Hoffmann +1 more
2003Maturitas33 citations
Semantic Scholar
Attitudes towards the menopause and hormone therapy over the turn of the century.
L. Lindh-Åstrand, J. Brynhildsen, M. Hoffmann, S. Liffner +1 more
2007Maturitas26 citations Open access
Semantic Scholar
Hormone replacement therapy in the menopause. Structure and content of risk talk.
M. Hoffmann, L. Lindh-Åstrand, J. Ahlner, M. Hammar +1 more
2004Maturitas26 citations
Semantic Scholar
Phases in development of an interactive mobile phone-based system to support self-management of hypertension
Inger Hallberg, C. Taft, A. Ranerup, U. Bengtsson +8 more
2014Integrated Blood Pressure Control25 citations Open access
Semantic Scholar
Hormone therapy might be underutilized in women with early menopause.
L. Lindh-Åstrand, M. Hoffmann, L. Järvstråt, M. Fredriksson +2 more
2015Human Reproduction24 citations Open access
Semantic Scholar
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees
M. Hoffmann
2013European Journal of Clinical Pharmacology24 citations Open access
Semantic Scholar
PERson-centredness in Hypertension management using Information Technology: a randomized controlled trial in primary care
U. Andersson, P. Nilsson, K. Kjellgren, M. Hoffmann +2 more
2022Journal of Hypertension21 citations Open access
Semantic Scholar
Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden
L. Lindh-Åstrand, M. Hoffmann, M. Hammar, Anna-Clara Spetz Holm
2015Climacteric21 citations Open access
Semantic Scholar
Risk talk: Rhetorical strategies in consultations on hormone replacement therapy
M. Hoffmann, Per Linell, L. Lindh-Åstrand, K. Kjellgren
200319 citations
Semantic Scholar
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
M. Hoffmann, R. Vander Stichele, D. Bates, Johanna Björklund +18 more
2020Expert Review of Clinical Pharmacology17 citations Open access
Semantic Scholar
Use of hormone therapy in Swedish women aged 80 years or older
Lotta Järvstråt, Anna-Clara Spetz Holm, L. Lindh-Åstrand, M. Hoffmann +2 more
2015Menopause16 citations Open access
Semantic Scholar
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
B. Godman, M. Władysiuk, S. McTaggart, A. Kurdi +40 more
2021BioMed Research International15 citations Open access
Semantic Scholar
PERson-centredness in hypertension management using information technology (PERHIT): a protocol for a randomised controlled trial in primary health care
P. Midlöv, P. Nilsson, U. Bengtsson, M. Hoffmann +6 more
2019Blood Pressure15 citations Open access
Semantic Scholar
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands
M. Jacobs, Jeroen F Schouten, P. D. de Boer, M. Hoffmann +2 more
2018Current Medical Research and Opinion14 citations Open access
Semantic Scholar
Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future
B. Godman, M. Wilcock, Andrew Martin, S. Bryson +35 more
201513 citations Open access
Semantic Scholar
Performance of 3 Sets of Criteria for Potentially Inappropriate Prescribing in Older People to Identify Inadequate Drug Treatment
S. Wallerstedt, S. Svensson, Johan Lönnbro, Fredrik Hieronymus +3 more
2022JAMA Network Open12 citations Open access
Semantic Scholar
Methodological issues in research on drug‐related admissions: A meta‐epidemiological review with focus on causality assessments
S. Wallerstedt, M. Hoffmann, Johan Lönnbro
2021British Journal of Clinical Pharmacology12 citations Open access
Semantic Scholar
Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
S. Wallerstedt, M. Hoffmann
2017British Journal of Clinical Pharmacology12 citations Open access
Semantic Scholar
Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021.
Micaela Sundell, J. Brynhildsen, Anna-Clara Spetz Holm, M. Fredrikson +1 more
2023Maturitas10 citations Open access
Semantic Scholar
Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study
L. Lindh-Åstrand, J. Brynhildsen, M. Hoffmann, K. Kjellgren +1 more
2007Menopause8 citations Open access
Semantic Scholar
Pulmonary embolism in menopausal hormone therapy: a population-based register study
Micaela Sundell, Anna-Clara Spetz Holm, M. Fredrikson, M. Hammar +2 more
2022Climacteric7 citations Open access
Semantic Scholar
Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia
Emmanuel Bäckryd, M. Heilig, M. Hoffmann
2021Scandinavian Journal of Pain7 citations Open access
Semantic Scholar
Challenges with Medication Management and the National Medication List in Sweden: An Interview Study from a Human, Organizational, and Technology Perspective
Tora Hammar, M. Hoffmann, L. Nilsson
2023Medical Informatics Europe4 citations Open access
Semantic Scholar
Do patients or their physicians more accurately assess long-term risk associated with hypertension? A population-based study
M. Hoffmann, P. Nilsson, J. Ahlner, B. Dahllöf +3 more
2020Scandinavian Journal of Primary Health Care4 citations Open access
Semantic Scholar
Evidence synthesis based on non-randomised studies—a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockers
S. Wallerstedt, M. Hoffmann
2019European Journal of Clinical Pharmacology4 citations Open access
Semantic Scholar
[GPs' perceptions of the Institute for Rational Pharmacotherapy].
C. Gudex, M. Hoffmann, O. Brørs, R. Dahlqvist
2009Ugeskrift for læger4 citations
Semantic Scholar
Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
M. Hoffmann, H. Støvring
2022Basic & Clinical Pharmacology & Toxicology3 citations Open access
Semantic Scholar
Timeline of and Expectations for the National Medication List in Sweden
M. Hoffmann
2023Medical Informatics Europe2 citations Open access
Semantic Scholar
PERSON-CENTREDNESS IN HYPERTENSION MANAGEMENT USING INFORMATION TECHNOLOGY (PERHIT): A RANDOMISED CONTROLLED TRIAL IN PRIMARY HEALTH CARE
Ulrika Andersson, K. Kjellgren, M. Hoffmann, André Wennersten +2 more
2022Journal of Hypertension2 citations Open access
Semantic Scholar
Utilization and costs of glucose lowering therapies following health technology assessment for the new reimbursement scheme in Sweden.
B. Pettersson, M. Hoffmann, D. Andersson, P. Wändell +1 more
2012Health Policy2 citations
Semantic Scholar
Comment on Häuser et al.: Medical use of opioids in Europe—Methodological concerns about data from the International Narcotics Control Board
Emmanuel Bäckryd, M. Heilig, M. Hoffmann
2022European Journal of Pain1 citations Open access
Semantic Scholar
Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
L. Lindh-Åstrand, M. Hoffmann, M. Fredrikson, M. Hammar +1 more
2019Maturitas1 citations Open access
Semantic Scholar
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees
M. Hoffmann
2013European Journal of Clinical Pharmacology1 citations Open access
Semantic Scholar
Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an example
M. Hoffmann, H. Støvring
2022Basic & Clinical Pharmacology & Toxicology0 citations Open access
Semantic Scholar
[PP.21.10] PATIENTS BETTER THAN PHYSICIANS IN ESTIMATING 10-YEAR RISK OF HYPERTENSION-RELATED CARDIOVASCULAR MORBIDITY – COHORT STUDY
M. Hoffmann, Peter M. Nilsson, Johan Ahlner, B. Dahlö;f +3 more
20170 citations
Semantic Scholar
Visualization of drug utilization data
M. Matuz, R. Benkő, M. Hoffmann
20160 citations
Semantic Scholar
Interactive Visualization of Prescriptions of Drugs to Individuals within Large Populations — Analyses of Temporal Relationships of Events
J. Johansson, Morten Andersen, Alexander Fridlund, M. Hoffmann
20120 citations
Semantic Scholar
Compliance to National Guidelines for Pharmaceutical Treatment of Sleeping Disorders among Elderly Incident Patients in Sweden in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol 20, issue , pp S203-S203
K. Lundberg, P. Johansson, M. Carlsson, A. Lemar +5 more
20110 citations
Semantic Scholar
External evaluation of the Institute for Rational Pharmacotherapy: Rapport til Lægemiddelstyrelsen
M. Hoffmann, O. Brørs, R. Dahlqvist, C. Gudex
20070 citations
Semantic Scholar
Selección de Resúmenes de Menopausia
Micaela Sundell, J. Brynhildsen, A. Holm, M. Fredrikson +11 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Hammar×11
Invite
M. Hammar — researcher profile on SciRah
K. Kjellgren×10
Invite
K. Kjellgren — researcher profile on SciRah
L. Lindh-Åstrand×10
Invite
L. Lindh-Åstrand — researcher profile on SciRah
M. Fredrikson×7
Invite
M. Fredrikson — researcher profile on SciRah

×6

Invite

J. Brynhildsen — researcher profile on SciRah

Invite

B. Godman — researcher profile on SciRah

Anna-Clara Spetz Holm×4

Invite

Anna-Clara Spetz Holm — researcher profile on SciRah

S. Wallerstedt×4

Invite

S. Wallerstedt — researcher profile on SciRah

B. Wettermark×3

Invite

B. Wettermark — researcher profile on SciRah

L. Gustafsson×3

Invite

L. Gustafsson — researcher profile on SciRah

Invite

J. Fürst — researcher profile on SciRah

K. Garuolienė×3

Invite

K. Garuolienė — researcher profile on SciRah